We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amphion Innovations Plc | LSE:AMP | London | Ordinary Share | GB00B0DJNP99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.15 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAMP
RNS Number : 5371B
Amphion Innovations PLC
10 January 2018
AMPHION INNOVATIONS PLC
("Amphion" or "the Company")
Directors' Dealings
London and New York, 10 January 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that on 5 January 2018 it granted options over ordinary shares in the Company ("Options") to certain of its directors as follows:
Director Amount Strike Vesting Price ---------------------- -------- ----------- ----------------------- Richard Mansell-Jones 563,000 1.94 pence Over one year starting as of 1 August 2017 ---------------------- -------- ----------- ----------------------- Miroslaw Izienicki 375,000 1.94 pence Over one year starting as of 1 August 2017 ---------------------- -------- ----------- -----------------------
All Options commence vesting backdated from 1 August 2017.
The strike price is based on the closing price on 4 January 2018, and the Options are exercisable on the date of vesting. Authority for the allotment of ordinary shares under the Share Option Scheme was approved as a part of the Company's Annual General Meeting.
In addition to the above Options allocation, the Company has issued 799,562 ordinary shares in the Company ("New Ordinary Shares"), representing 0.38% of the enlarged issued share capital, to certain of its Board members (current and former) in payment of directors' fees due them. The issue of Ordinary Shares is calculated based on the closing mid-market price for the five days leading up to the close on 4 January 2018. Following this issue the current directors' shareholdings in the Company are as follows:
Director Number of Total Shareholding Percentage New Ordinary of Shares Voting Rights ----------------------- -------------- ------------------- --------------- Miroslaw Izienicki 193,791 795,280 0.379% ----------------------- -------------- ------------------- --------------- Richard Mansell-Jones 558,896 4,344,426 2.069% ----------------------- -------------- ------------------- --------------- Gerard Moufflet (former director) 46,875 1,320,833 0.629% ----------------------- -------------- ------------------- ---------------
Admission of the 799,562 New Ordinary Shares, ranking pari passu with the existing ordinary shares, to trading on AIM is expected on 17 January 2018. Following the issue and allotment of the New Ordinary Shares, the total issued share capital of the Company will increase to 209,975,450 ordinary shares with each share holding one voting right. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR").
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated === =============================================================== a) Name Richard Mansell-Jones === =============================== ============================== 2 Reason for the notification === =============================================================== a) Position/status Chairman and PDMR === =============================== ============================== b) Initial notification/Amendment Initial notification === =============================== ============================== 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================== a) Name Amphion Innovations plc === =============================== ============================== b) LEI 213800M7MTE2W2P6C104 === =============================== ============================== 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === =============================================================== a) Description Ordinary Shares of the financial instrument, type of instrument === =============================== ============================== b) Nature of the Richard Mansell-Jones has transaction received new Ordinary Shares in lieu of fees === =============================== ============================== c) Price(s) and 558,896 Ordinary Shares volume(s) === =============================== ============================== d) Aggregated information - Aggregated N/A (Single transaction) volume - Price === =============================== ============================== e) Date of the 5 January 2018 transaction === =============================== ============================== f) Place of the Outside a trading venue transaction === =============================== ============================== 1 Details of the person discharging managerial responsibilities/person closely associated === ================================================================= a) Name Miroslaw Izienicki === =============================== ================================ 2 Reason for the notification === ================================================================= a) Position/status Non-executive Director and PDMR === =============================== ================================ b) Initial notification/Amendment Initial notification === =============================== ================================ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================= a) Name Amphion Innovations plc === =============================== ================================ b) LEI 213800M7MTE2W2P6C104 === =============================== ================================ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ================================================================= a) Description Ordinary Shares of the financial instrument, type of instrument === =============================== ================================ b) Nature of the Miroslaw Izienicki has received transaction new Ordinary Shares in lieu of fees === =============================== ================================ c) Price(s) and 193,791 Ordinary Shares volume(s) === =============================== ================================ d) Aggregated information - Aggregated N/A (Single transaction) volume - Price === =============================== ================================ e) Date of the 5 January 2018 transaction === =============================== ================================ f) Place of the Outside a trading venue transaction === =============================== ================================ 1 Details of the person discharging managerial responsibilities/person closely associated === ============================================================= a) Name Richard Mansell-Jones === =============================== ============================ 2 Reason for the notification === ============================================================= a) Position/status Chairman and PDMR === =============================== ============================ b) Initial notification/Amendment Initial notification === =============================== ============================ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================= a) Name Amphion Innovations plc === =============================== ============================ b) LEI 213800M7MTE2W2P6C104 === =============================== ============================ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been conducted === ============================================================= a) Description Options to acquire Ordinary of the financial Shares instrument, type of instrument === =============================== ============================ b) Nature of the Grant of options to acquire transaction Ordinary Shares === =============================== ============================ c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- 1.94p 563,000 --------- ---------- === =============================== ============================ d) Aggregated information - Aggregated N/A (Single transaction) volume - Price === =============================== ============================ e) Date of the 5 January 2018 transaction === =============================== ============================ f) Place of the Outside a trading venue transaction === =============================== ============================ 1 Details of the person discharging managerial responsibilities/person closely associated === ============================================================= a) Name Miroslaw Izienicki === =============================== ============================ 2 Reason for the notification === ============================================================= a) Position/status Non-executive Director and PDMR === =============================== ============================ b) Initial notification/Amendment Initial notification === =============================== ============================ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================= a) Name Amphion Innovations plc === =============================== ============================ b) LEI 213800M7MTE2W2P6C104 === =============================== ============================ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ============================================================= a) Description Options to acquire Ordinary of the financial Shares instrument, type of instrument === =============================== ============================ b) Nature of the Grant of options to acquire transaction Ordinary Shares === =============================== ============================ c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- 1.94p 375,000 --------- ---------- === =============================== ============================ d) Aggregated information - Aggregated N/A (Single transaction) volume - Price === =============================== ============================ e) Date of the 5 January 2018 transaction === =============================== ============================ f) Place of the Outside a trading venue transaction === =============================== ============================
For further information please contact:
Amphion Innovations Tel: +1 (212) 210 6224 Charlie Morgan Panmure Gordon (UK) Limited (Nominated Tel: +44 (0)20 Adviser and Corporate Broker) 7886 2500 Freddy Crossley / Ryan McCarthy (Corporate Finance) Charlie Leigh-Pemberton (Corporate Broking) Northland Capital Partners Tel: +44 (0)20 3861 Limited (Joint Corporate Broker) 6625 Patrick Claridge / David Hignell (Corporate Finance) John Howes (Corporate Broking) Walbrook PR Tel: +44 (0)20 7933 8780 or Anna Dunphy / Paul McManus amphion@walbrookpr.com
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and technology businesses. We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDBLFFVFFBBBV
(END) Dow Jones Newswires
January 10, 2018 12:09 ET (17:09 GMT)
1 Year Amphion Innovations Chart |
1 Month Amphion Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions